EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Network pharmacology and machine learning-driven virtual screening with dynamic simulations of natural compounds for glioblastoma

Temitope C. Aribigbola, Damilola A. Omoboyowa, Mohit Agrawal, Abayomi O. Adelaja, Babasola Aiyeku, Magdi E.A. Zaki

Letters in Drug Design & Discovery · 2026-02 · 23 (2) · 100376

DOI: 10.1016/j.lddd.2026.100376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-02. Verfasst von Temitope C. Aribigbola und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Aribigbola, T. C., Omoboyowa, D. A., Agrawal, M., Adelaja, A. O., Aiyeku, B., & Zaki, M. E. (2026). Network pharmacology and machine learning-driven virtual screening with dynamic simulations of natural compounds for glioblastoma. Letters in Drug Design & Discovery, 23(2), 100376. https://doi.org/10.1016/j.lddd.2026.100376

Vancouver

Aribigbola TC, Omoboyowa DA, Agrawal M, Adelaja AO, Aiyeku B, Zaki ME. Network pharmacology and machine learning-driven virtual screening with dynamic simulations of natural compounds for glioblastoma. Letters in Drug Design & Discovery. 2026;23(2):100376. doi:10.1016/j.lddd.2026.100376

BibTeX
@article{Aribigbola2026,
  author = {Aribigbola, Temitope C. and Omoboyowa, Damilola A. and Agrawal, Mohit and Adelaja, Abayomi O. and Aiyeku, Babasola and Zaki, Magdi E.A.},
  title = {Network pharmacology and machine learning-driven virtual screening with dynamic simulations of natural compounds for glioblastoma},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {100376},
  doi = {10.1016/j.lddd.2026.100376}
}
Kostenlos starten →